{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T22:06:33Z","timestamp":1765231593097,"version":"3.32.0"},"reference-count":8,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T00:00:00Z","timestamp":1120176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T00:00:00Z","timestamp":1120176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2005,7]]},"DOI":"10.1136\/ard.2004.032110","type":"journal-article","created":{"date-parts":[[2005,6,15]],"date-time":"2005-06-15T20:13:30Z","timestamp":1118866410000},"page":"1090-1091","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Etanercept in treatment of Felty's syndrome"],"prefix":"10.1016","volume":"64","author":[{"given":"A","family":"Ghavami","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Genevay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Fulpius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Gabay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1136\/ard.2004.032110_bib1","first-page":"1163","article-title":"The clinical course of Felty's syndrome compared to matched controls","volume":"18","author":"Sibley","year":"1991","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2004.032110_bib2","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1136\/ard.41.5.486","article-title":"Long-term outcome in Felty's syndrome","volume":"41","author":"Thorne","year":"1982","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2004.032110_bib3","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1056\/NEJM197705192962016","article-title":"Immunosuppressive therapy in Felty's syndrome","volume":"296","author":"Wiesner","year":"1977","journal-title":"N Engl J Med"},{"key":"10.1136\/ard.2004.032110_bib4","first-page":"868","article-title":"Treatment of Felty's syndrome with leflunomide","volume":"28","author":"Talip","year":"2001","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2004.032110_bib5","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1093\/rheumatology\/37.8.908","article-title":"Methotrexate treatment in Felty's syndrome","volume":"37","author":"Wassenberg","year":"1998","journal-title":"Br J Rheumatol"},{"key":"10.1136\/ard.2004.032110_bib6","first-page":"599","article-title":"Oral methotrexate in the treatment of Felty's syndrome","volume":"20","author":"Tan","year":"1993","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2004.032110_bib7","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1034\/j.1600-0609.2003.00115.x","article-title":"Aplastic anemia following administration of a tumor necrosis factor-alpha inhibitor","volume":"71","author":"Kuruvilla","year":"2003","journal-title":"Eur J Haematol"},{"key":"10.1136\/ard.2004.032110_bib8","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1093\/rheumatology\/keh128","article-title":"Case report: Response in proteinuria due to AA amyloidosis but not Felty's syndrome in a patient with rheumatoid arthritis treated with TNF-alpha blockade","volume":"43","author":"Ravindran","year":"2004","journal-title":"Rheumatology (Oxford)"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724429476?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724429476?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.2004.032110","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T05:22:22Z","timestamp":1736140942000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724429476"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7]]},"references-count":8,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2005,7]]}},"alternative-id":["S0003496724429476"],"URL":"https:\/\/doi.org\/10.1136\/ard.2004.032110","relation":{},"ISSN":["0003-4967"],"issn-type":[{"type":"print","value":"0003-4967"}],"subject":[],"published":{"date-parts":[[2005,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Etanercept in treatment of Felty's syndrome","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.2004.032110","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Copyright 2005 by Annals of the Rheumatic Diseases, Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}